Materials and methods for treating and managing angiogenesis-mediated diseases

Details for Australian Patent Application No. 2011202132 (hide)

Owner Pervasis Therapeutics, Inc.

Inventors Nugent, Helen Marie; Edelman, Elazer R.; Tjin Tham Sjin, Robert M.; Ng, Yin Shan

Agent Griffith Hack

Pub. Number AU-B-2011202132

Parent 2007317789

Filing date 9 May 2011

Wipo publication date 26 May 2011

Acceptance publication date 20 September 2012

International Classifications

A61K 35/12 Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61F 2/06 Filters - Blood vessels

A61L 27/38 Materials for prostheses or for coating prostheses

A61L 29/16 Materials for catheters or for coating catheters

A61P 19/02 Drugs for skeletal disorders

A61P 37/00 Drugs for immunological or allergic disorders

A61P 43/00 Drugs for specific purposes, not provided for in groups

Event Publications

26 May 2011 Application Open to Public Inspection

  Published as AU-B-2011202132

26 May 2011 Complete Application Filed

20 September 2012 Application Accepted

  Published as AU-B-2011202132

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202133-An isolation means for a distribution board

2011202131-Paper substrates containing high surface sizing and low internal sizing and having high dimensional stability